University of Oregon to Provide Abortion Pills on Campus

The University of Oregon has announced that, beginning this fall, it will offer abortion pills to students at the University Health Center.

This decision includes distributing mifepristone and misoprostol, medications used in the abortion process. Mifepristone works by blocking progesterone—an essential hormone for maintaining pregnancy—and this is typically followed by misoprostol to finalize the procedure.

A recent report highlighted some concerns regarding the use of these medications. For instance, an analysis from the Ethics and Public Policy Center noted that around 10.93% of women might experience serious complications, such as infections or severe bleeding, within 45 days of taking mifepristone.

The move to provide abortion pills on campus was, in part, driven by initiatives from student organizations like College Students for Choice and the Young Democratic Socialists of America at the University of Oregon. These groups have been actively campaigning for improved access to abortion services on campus for the past three years. “Starting this fall, we will make it our primary focus,” stated a representative from YDSA.

Carly Windle, the president of UO Students for Choice, remarked, “It’s significant to see abortion access expanding in our community, especially when access is shrinking in other areas and people are facing severe consequences.” She also emphasized that having abortion pills available on campus would be particularly beneficial for students who lack reliable transportation.

Windle added that the logistical hurdles posed by needing to travel off-campus, such as relying on rideshare services, really complicate an already challenging situation.

The university’s decision aligns with the broader discussions around reproductive health services and access for students, especially at a time when such services are under increasing scrutiny in various regions.